Tools

LEADER 04389cam 22005297i 4500

001 ssj0001692786;

003 WaSeSS;

005 20220112082112.0;

006 m d ;

007 cr n ;

008 160630t20152015dcua sb 100 0 eng d;

010 a| 2016427584;

020 a| 9780309373234;

020 a| 0309373239;

035 a| (WaSeSS)ssj0001692786;

042 a| lccopycat;

049 a| EREEa| NEHH;

050 00 a| RM301.25b| .N67 2015;

082 00 a| 615.1/92| 23;

100 1 a| Norris, Sheena M. Posey.=| ^A1334003;

245 10 a| Financial incentives to encourage development of therapies that address unmet medical needs for nervous system disordersh| [electronic resource] :b| workshop summary /c| Sheena M. Posey Norris, Evelyn Strauss, Christopher DeFeo, and Clare Stroud, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.;

260 a| Washington, D.C. :b| The National Academies Press,c| [2015];

300 a| xiv, 114 pages :b| color illustrations ;c| 23 cm;

504 a| Includes bibliographical references (pages 61-64).;

505 0 a| Introduction and overview. Workshop objectives -- Organization of the report -- Unmet medical needs in nervous system disorders -- Topics highlighted during presentations and discussions -- Improving market protection. How companies make decisions -- Business implications of the stagnant R&D climate for CNS drugs -- Overview of the current intellectual property (IP) environment for the private sector -- Legislation establishing market protection periods -- Potential new approaches to extending market protection -- Opportunities to incentivize R&D through improved market protection -- Strenghtening the regulatory pathway. Drug development -- Regulatory challenges specific to CNS disorders -- Potential mechanisms to address regulaltory challenges -- Clarity or regulatory processes and decisions -- Reimbursement -- Opportunities to incentivize R&D by strenghtening regulatory pathways -- Patient benefit and engagement. Patient involvement -- Determining value to patients -- Creatively engaging public-private partneships, advocacy groups, and nonprofit health organizations -- Opportunity to encourage patient involvement in the drug development process.;

506 a| Available only to authorized users.;

530 a| Also issued online.;

538 a| Mode of access: World Wide Web;

650 0 a| Drug developmentx| Economic aspectsv| Congresses.=| ^A443888;

650 0 a| Pharmaceutical industryx| Economic aspectsv| Congresses.=| ^A3655;

650 0 a| Public-private sector cooperationv| Congresses.=| ^A400816;

655 0 a| Electronic books.=| ^A491897;

710 2 a| Institute of Medicine (U.S.).b| Forum on Neuroscience and Nervous System Disorders.=| ^A1035761;

711 2 a| Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders (Workshop)d| (2015 :c| Washington, D.C.),j| author=| ^A1334344;

776 08 a| Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders (Workshop) (2015 : Washington, D.C.).t| Financial incentives to encourage development of therapies that address unmet medical needs for nervous system disorders.d| Washington, D.C. : National Academies Press, [2015]z| 9780309373241w| (OCoLC)927362841;

856 40 z| Full text available from Ebook Central - Academic Completeu| https://ebookcentral.proquest.com/lib/eastcarolina/detail.action?docID=4393789;

947 a| (OCoLC)ocn921241584;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 5646185;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5646185-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 7/19/2021x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5646185-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 7/19/2021x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5646185-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 7/19/2021x| EBOOKz| JERESOURCE;

Financial incentives to encourage development of therapies that address unmet medical needs for nervous system disorders workshop summary / Sheena M. Posey Norris, Evelyn Strauss, Christopher DeFeo, and Clare Stroud, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

Author/creator	Norris, Sheena M. Posey
Other author	Institute of Medicine (U.S.). Forum on Neuroscience and Nervous System Disorders.
Other author	Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders (Workshop) (2015 : Washington, D.C.),
Format	Electronic
Publication Info	Washington, D.C. : The National Academies Press, [2015]
Description	xiv, 114 pages : color illustrations ; 23 cm
Supplemental Content	Full text available from Ebook Central - Academic Complete
Subjects	Drug development--Economic aspects. --Congresses. Central nervous system--Diseases. --Effect of drugs on. --Congresses. Pharmaceutical industry--Economic aspects. --Congresses. Public-private sector cooperation--Congresses.

Contents	Introduction and overview. Workshop objectives -- Organization of the report -- Unmet medical needs in nervous system disorders -- Topics highlighted during presentations and discussions -- Improving market protection. How companies make decisions -- Business implications of the stagnant R&D climate for CNS drugs -- Overview of the current intellectual property (IP) environment for the private sector -- Legislation establishing market protection periods -- Potential new approaches to extending market protection -- Opportunities to incentivize R&D through improved market protection -- Strenghtening the regulatory pathway. Drug development -- Regulatory challenges specific to CNS disorders -- Potential mechanisms to address regulaltory challenges -- Clarity or regulatory processes and decisions -- Reimbursement -- Opportunities to incentivize R&D by strenghtening regulatory pathways -- Patient benefit and engagement. Patient involvement -- Determining value to patients -- Creatively engaging public-private partneships, advocacy groups, and nonprofit health organizations -- Opportunity to encourage patient involvement in the drug development process.
Bibliography note	Includes bibliographical references (pages 61-64).
Access restriction	Available only to authorized users.
Other forms	Also issued online.
Technical details	Mode of access: World Wide Web
Issued in other form	Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders (Workshop) (2015 : Washington, D.C.). Financial incentives to encourage development of therapies that address unmet medical needs for nervous system disorders. Washington, D.C. : National Academies Press, [2015] 9780309373241
Genre/form	Electronic books.
LCCN	2016427584
ISBN	9780309373234
ISBN	0309373239

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Click here for more information about this title

Availability